Copellor auto 80mg Pen Injection contains an active component as ixekizumab. It is a prescription medication for certain inflammatory conditions, primarily moderate to severe plaque psoriasis and psoriatic arthritis. Severe plaque psoriasis is a chronic autoimmune skin condition characterized by thick, red, and scaly patches. At the same time, psoriatic arthritis is an inflammatory condition that affects the joints and is often associated with psoriasis. This medication belongs to a class of drugs called interleukin inhibitors. Copellor auto 80mg Pen Injection has been shown to have a rapid onset of action, with noticeable improvements in skin symptoms and joint pain often seen within the first few weeks of treatment.

Copellor auto 80mg Pen Injection should not be used in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. This medication may increase the risk of infections. Therefore, it is generally not recommended to start treatment with this medication in individuals with active infections, including localized or systemic infections. Live vaccines should not be administered concurrently with Copellor auto 80mg Pen Injection. In individuals with a history of HBV infection, the virus may reactivate during or after treatment with the use o this medication. Close monitoring and appropriate management strategies are necessary in these cases.

Copellor auto 80mg Pen Injection is used in treating the following:

• Plaque psoriasis
• Psoriatic arthritis

The therapeutic effect of Copellor auto 80mg Pen Injection is the reduction of inflammation and improvement of symptoms in individuals with severe plaque psoriasis and psoriatic arthritis. By specifically targeting and blocking the action of interleukin-17A (IL-17A), this medication helps to modulate the immune response, leading to a decrease in skin inflammation, scaling, redness, and joint pain. This results in a visible improvement in the appearance of psoriatic skin lesions and a reduction in joint swelling, stiffness, and discomfort, ultimately enhancing the quality of life for patients affected by these conditions.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Copellor auto 80mg Pen Injection, reducing effectiveness by causing undesirable side effects.

• Stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

To use Copellor auto 80mg Pen Injection, follow the instructions provided by your healthcare provider or as indicated on the medication label. It is typically administered as an injection under the skin. The exact dosing and administration instructions may vary based on the specific condition being treated.

Side Effects:

Copellor auto 80mg Pen Injection causes some side effects like all medications, although not everyone will experience them. 

Serious:

• Infections
• Allergic reactions
• Inflammatory bowel disease (IBD)
• Hepatitis B virus (HBV) reactivation
• Depression or suicidal thoughts

Common:

• Nausea
• Vomiting
• Injection site reactions
• Upper respiratory tract infections
• Headache

It is vital to approach the use of Copellor auto 80mg Pen Injection with caution and adhere to necessary precautions. Before starting treatment, discuss any pre-existing conditions, including liver disease, and inform your healthcare provider of any medications you are currently taking to avoid potential drug interactions. Be aware of the warnings associated with this medication, such as the risk of serious infections, including tuberculosis, and the possibility of reactivating latent tuberculosis infection. Pregnant and breastfeeding women should consult a doctor before starting the treatment. Regular monitoring for signs of infection, allergic reactions, or the development of inflammatory bowel disease is crucial. Additionally, stay vigilant for symptoms of depression, suicidal thoughts, or mood disorders, and promptly seek medical attention. Take precautions to minimize the risk of exposure to live vaccines and consider individual factors, such as cardiovascular risk factors and prior history of malignancies.

1. Eli Lilly and Company, Electronic medicines compendium (EMC), [Revised on 25 May 2023], [Accessed on 17th June 2023], https://www.medicines.org.uk/emc/product/8199/pil#gref
2. Eli Lilly and Company, US Food and Drug Administration, [Revised on March 2021], [Accessed on 17th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125521s014lbl.pdf